聚维 operates in industrial manufacturing and bioprocess engineering, with a tech stack centered on CAD tools (UG NX, CATIA, SolidWorks, AutoCAD) and automation platforms (Siemens PLC, HMI) alongside custom C/C++/C# development. The project portfolio reveals a fermentation-focused operation: microbial secondary metabolism validation, fermentation workshop optimization, and scale-up production dominate the roadmap. Pain points cluster around process reliability, efficiency gains, and cost reduction — typical of biotech/pharma manufacturing scaling.
聚维 is a small Beijing-based firm specializing in fermentation process development and manufacturing optimization. The company blends industrial engineering (CAD/CAM, PLC automation) with microbiology and chemical engineering, delivering process design, equipment selection, and software solutions for bioprocess clients. Current work centers on fermentation efficiency, production scale-up, and process simplification — particularly reducing deviation and production cost in existing fermentation workflows. The engineering-dominated team (9 of 15 staff) and seniority skew (6 senior, 5 mid-level) suggest deep domain expertise rather than early-stage product development.
UG NX, CATIA, SolidWorks, and AutoCAD; also works with Siemens PLC and HMI for industrial automation.
Fermentation process R&D (microbial secondary metabolism validation, scale-up production), manufacturing optimization, and process improvement in fermentation workshops and machining.
China only. The company has 15 active roles across engineering (9), sales (3), finance (1), manufacturing (1), and research (1), with minimal hiring velocity.
Other companies in the same industry, closest in size